Syndax Pharmaceuticals Inc (NAS:SNDX)
$ 20.81 -0.41 (-1.93%) Market Cap: 1.84 Bil Enterprise Value: 1.83 Bil PE Ratio: 0 PB Ratio: 44.28 GF Score: 20/100

Syndax Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 11:00 PM GMT
Release Date Price: $20.72 (-1.33%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SNDX.OQ - Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc at JPMorgan Healthcare Conference
Jan 12, 2026 / 11:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Okay, we'll go ahead and get started.

Welcome everyone to the forty-fourth annual JP Morgan Healthcare Conference. My name is Anu Pamrama, I'm one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Priyanka Grover, Rati Pinhey, and Joyces.

Our next presenting company is Syndax, and presenting on behalf of the company, we have CEO Michael Metzger. Michael.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Anna Palm. Nice to see everybody. Thanks for joining us.

Thank you to JP Morgan for the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot